Our Pipeline
Investors
Indication
Geography
Pre-Clinical Research
Feasibility Trial
Pivotal Trial
Marketing Authorization
Skin Cancer
US
Table of Contents
- Pre-Clinical Research
- Feasibility Trial
- Pivotal Trial
- Marketing Authorization
Skin Cancer
U.S
Recruiting patients for cutaneous squamous cell carcinoma trial in the United States
Israel
Advanced skin squamous cell carcinoma treatment in Israel
Japan
Skin cancer treatment development in Japan
Head & Neck Cancer
Israel
Oral cavity squamous cell carcinoma treatment in Israel
Israel - Ly/mHNSCC
Combination therapy with Pembrolizumab for head and neck cancer
Pancreatic Cancer
Israel
Pancreatic cancer treatment research in Israel
U.S
Early-stage pancreatic cancer research in the United States
Canada
Pancreatic cancer treatment development in Canada
Europe
Early-stage pancreatic cancer research in Europe
Japan
Early-stage pancreatic cancer research in Japan
Brain (GBM + mets)
Israel
Glioblastoma multiforme and metastases treatment research in Israel
U.S
Early-stage brain cancer research in the United States
Liver Metastases
Canada
Liver metastases treatment research in Canada
Lung Cancer
Israel
Lung cancer treatment development in Israel
Prostate Cancer
Israel
Prostate cancer treatment research in Israel
Vulvar Cancer
U.K
Vulvar cancer treatment development in the United Kingdom
Clinical Pipeline
Alpha Tau Medical — Alpha DaRT Technology
← Swipe to see full pipeline →
| Indication | Geography | Pre-Clinical Research |
Feasibility Trial |
Pivotal Trial | Marketing Authorization |
|---|